From Hazelden Betty Ford <[email protected]>
Subject Genetic Research for Addiction Treatment
Date July 21, 2020 10:38 AM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Finding the most-effective treatment medication for each individual.

View Online [link removed]

New Frontiers in Addiction Medicine: Genetic Research and Biomarkers

What if a simple blood test indicated the most-effective treatment medication for individuals with alcohol or opioid addiction? "Biomarker" research underway by Mayo Clinic and Hazelden Betty Ford aims to provide that very insight. Listen in as host William C. Moyers talks with addiction psychiatrist Marvin D. Seppala, MD, about how these scientific investigations at the genetic and cellular level will inform precision treatment for patients and lead to development of new addiction medications.

Listen now or read the podcast transcript to learn more about genetic research and biomarkers at [link removed]

You are receiving this message because you've registered or accepted our invitation to receive email from the Hazelden Betty Ford Foundation.

Preferences [link removed] | Unsubscribe [link removed]

[link removed]

[link removed]

[link removed]

[link removed]

[link removed]

[link removed]

[link removed]

Hazelden Betty Ford Foundation
15251 Pleasant Valley Rd.
PO Box 11 RW19
Center City, MN 55012-0011

81087EPPL
Screenshot of the email generated on import

Message Analysis